 |
- Condition: Influenza
Interventions: Biological: NBP607-QIV; Biological: Agrippal
Sponsor: SK Bioscience Co., Ltd.
Not yet recruiting - Condition: Influenza A Subtype H5N1 Infection
Intervention: Biological: Seasonal Influenza Vaccine
Sponsors: Emory University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Influenza; Organ Transplantation
Interventions: Biological: High-dose influenza vaccine; Biological: MF59-adjuvanted influenza vaccine; Biological: Standard intramuscular influenza vaccine
Sponsors: Oriol Manuel; University Hospital, Basel, Switzerland; University of Bern; University Hospital, Geneva; University of Zurich; Cantonal Hospital of St. Gallen; Fondazione Epatocentro Ticino
Not yet recruiting - Condition: Influenza
Interventions: Biological: QIV-HD, 30 µg HA/strain/dose; Biological: QIV-HD, 45 µg µg HA/strain/dose; Biological: QIV-HD 60 µg HA/strain/dose; Biological: Unadjuvanted QIV-SD, 15 µg HA/strain/dose; Biological: Adjuvanted TIV, 7.5 µg HA/strain/dose
Sponsor: Sanofi Pasteur, a Sanofi Company
Recruiting - Condition: Rehabilitation, Tenodesis, Stroke
Intervention: Other: Motor task specific training
Sponsor: National Cheng-Kung University Hospital
Not yet recruiting - Condition: Flu
Interventions: Drug: Fluad Vaccine; Drug: Fluzone HD Vaccine
Sponsors: David H. Canaday; Case Western Reserve University; US Department of Veterans Affairs; Brown University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza, Human
Intervention: Other: Passive enhanced safety surveillance
Sponsor: GlaxoSmithKline
Not yet recruiting - Condition: Influenza
Intervention: Biological: Seasonal influenza vaccine 2018-2019
Sponsor: Emory University
Not yet recruiting - Condition: Influenza
Interventions: Drug: Baloxavir Marboxil; Other: Placebo
Sponsor: Hoffmann-La Roche
Not yet recruiting - Conditions: Avian Influenza; Influenza Immunisation
Interventions: Biological: A/H7N9; Drug: MF59 adjuvant; Other: Phosphate Buffered Saline (PBS) diluent
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Conditions: Influenza; Pneumonia; Lower Respiratory Tract Infection; Acute Myocardial Infarction; Congestive Heart Failure; Stroke
Interventions: Biological: Flublok Quadrivalent; Biological: Standard Dose Inactivated Influenza Vaccine (SD-IIV)
Sponsors: Kaiser Permanente; Sanofi Pasteur, a Sanofi Company
Recruiting - Conditions: Influenza; Influenza Immunisation
Intervention: Biological: Influenza Virus Quadrivalent Inactivated Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza
Interventions: Biological: aTIV Primer; Biological: QIV Primer; Biological: aTIV Booster; Biological: QIV Booster
Sponsors: Canadian Immunization Research Network; Provincial Health Services Authority; McGill University Health Center; Université de Montréal; Canadian Center for Vaccinology; McMaster University; CHU de Quebec-Universite Laval; Dalhousie University
Not yet recruiting - Condition: Influenza
Interventions: Drug: ZSP1273 100 mg; Drug: Placebo 100 mg; Drug: ZSP1273 200 mg; Drug: Placebo 200 mg; Drug: ZSP1273 400 mg; Drug: Placebo 400 mg; Drug: ZSP1273 600 mg; Drug: Placebo 600 mg; Drug: ZSP1273 900 mg; Drug: Placebo 900 mg; Drug: ZSP1273 1200 mg; Drug: Placebo 1200 mg; Drug: ZSP1273; Drug: Placebo; Drug: ZSP1273 Low Dose; Drug: ZSP1273 Median Dose; Drug: ZSP1273 High Dose
Sponsor: Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Not yet recruiting - Condition: Influenza, Human
Interventions: Biological: 2018-2019 Investigational Seasonal Influenza Vaccine; Biological: 2018-2019 Licensed Seasonal Influenza Vaccine; Other: Placebo
Sponsor: Novavax
Recruiting - Condition: Influenza, Human
Interventions: Biological: GC3114; Biological: GCFLU Quadrivalent
Sponsor: Green Cross Corporation
Recruiting - Condition: Influenza
Intervention: Drug: Baloxavir Marboxil
Sponsor: Hoffmann-La Roche
Not yet recruiting - Conditions: Influenza A Virus Infection; Influenza A; Influenza Epidemic; Influenza H5N1
Intervention: Biological: GamFluVac
Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Recruiting - Condition: Influenza Vaccination
Intervention: Other: Communication intervention
Sponsors: University of Warwick; University Hospital Birmingham
Recruiting - Condition: Influenza
Interventions: Drug: Baloxavir Marboxil; Drug: Oseltamivir
Sponsor: Hoffmann-La Roche
Not yet recruiting - Condition: Influenza
Interventions: Biological: Fluzone Quadrivalent vaccine, 2018-2019 formulation; Biological: Flublok Quadrivalent vaccine, 2018-2019 formulation; Biological: Fluzone High-Dose vaccine, 2018-2019 formulation
Sponsor: Sanofi Pasteur, a Sanofi Company
Recruiting - Condition: Influenza Virus Infection
Intervention:
Sponsor: Renmin Hospital of Wuhan University
Not yet recruiting - Conditions: Influenza, Human; Immune Response
Interventions: Biological: Flucelvax inactivated influenza vaccine; Biological: Fluzone inactivated influenza vaccine
Sponsors: Richard Zimmerman; Centers for Disease Control and Prevention
Recruiting - Condition: PTEN Hamartoma Tumor Syndrome
Intervention: Biological: Influvac Tetra
Sponsor: Radboud University
Not yet recruiting - Condition: Influenza
Interventions: Drug: Fluad Vaccine; Drug: Fluzone High-Dose
Sponsors: Mayo Clinic; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Conditions: Influenza; Influenza-like Illness; Influenza, Human
Intervention: Biological: Influenza
Sponsors: Insight Therapeutics, LLC; Seqirus; Brown University
Recruiting - Condition: Pneumococcal Infections
Interventions: Biological: V114; Biological: QIV; Biological: Placebo
Sponsor: Merck Sharp & Dohme Corp.
Recruiting - Condition: Influenza
Interventions: Diagnostic Test: Ellume Home Flu Test; Diagnostic Test: ellume.lab Flu A+B Test; Diagnostic Test: Reverse Transcriptase Polymerase Chain Reaction (RT-PCR); Diagnostic Test: Viral culture
Sponsor: Ellume Pty Ltd
Recruiting - Conditions: Avian Influenza; Influenza Immunisation
Interventions: Biological: A/H7N9; Drug: AS03; Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013; Other: Phosphate Buffered Saline (PBS) diluent
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Influenza; Solid Carcinoma
Intervention: Biological: Influenza vaccination
Sponsors: Seoul National University Hospital; Green Cross Corporation
Not yet recruiting - Conditions: Asthma in Children; Vaccine Adverse Reaction; Vaccine Reaction; Asthma; Wheezing; Influenza
Interventions: Biological: Live Attenuated Influenza Vaccine (LAIV); Biological: Inactivated Influenza Vaccine (IIV)
Sponsors: Vanderbilt University Medical Center; Centers for Disease Control and Prevention; Duke University; Children's Hospital Medical Center, Cincinnati
Recruiting - Condition: Influenza
Interventions: Biological: OVX836 (Intramuscular); Biological: Placebo (Intramuscular); Biological: OVX836 (Intranasal); Biological: Placebo (Intranasal)
Sponsors: Osivax S.A.S; Aepodia
Recruiting - Condition: Influenza
Interventions: Biological: H7N3 pLAIV; Biological: H7N9 pIIV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Respiratory Tract Infections
Intervention:
Sponsor: Janssen-Cilag International NV
Recruiting - Conditions: Influenza; Influenza Immunisation
Interventions: Biological: Influenza Virus Monovalent A/H3N2/Bris 10 M2SR Live Vaccine; Other: Placebo; Biological: Quadrivalent MDCK Inactivated Influenza Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Healthy
Interventions: Biological: sIPV; Biological: cIPV
Sponsor: Janssen Vaccines & Prevention B.V.
Recruiting - Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Metformin/Vildagliptin
Sponsor: Clinision
Not yet recruiting - Conditions: Smoking Cessation; Smoking, Cigarette; Smoking; Stress; Stress, Psychological; Health Behavior; Smoking, Tobacco
Interventions: Behavioral: Stress management program (SM); Behavioral: Stress management + Buddy program (SM-B)
Sponsors: Erasmus Medical Center; Indigo Rijnmond, the Netherlands; Avant Sanare, The Netherlands; Erasmus University College, The Netherlands
Recruiting - Conditions: Systemic Lupus; Sjogren's Syndrome
Intervention: Biological: Inactivated and fragmented influenza vaccine (A / Michigan / 45/2015 (H1N1) pdm09-like virus, A / Singapore / INFIMH-16-0019 / 2016 (H3N2) -like virus; B / Phuket / 3073/2013-like virus)
Sponsor: University of Sao Paulo General Hospital
Recruiting - Condition: Influenza A
Interventions: Drug: CT-P27 Dose1; Drug: CT-P27 Dose2; Drug: Placebo
Sponsor: Celltrion
Recruiting - Conditions: Acute Myeloid Leukemia; Allogeneic Hematopoietic Stem Cell Transplantation; Conditioning; Elderly
Interventions: Drug: Decitabine; Drug: Busulfan (BU); Drug: Fludarabine(Flu)
Sponsors: Nanfang Hospital of Southern Medical University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Guangzhou First People's Hospital; Peking University People's Hospital; Third Affiliated Hospital, Sun Yat-Sen University; Zhujiang Hospital
Recruiting - Conditions: Symptoms Flu; Symptoms Cold
Interventions: Dietary Supplement: Whole Cell Euglena containing Beta Glucan; Dietary Supplement: Placebo
Sponsors: Kemin Foods LC; KGK Science Inc.
Recruiting - Condition: Healthy
Interventions: Biological: Placebo; Biological: RSV preF Protein 50 mcg; Biological: RSV preF Protein 150 mcg; Biological: Ad26.RSV.preF 1*10^11 vp; Biological: Mixture of Ad26.RSV.preF 5*10^10 vp Plus RSV preF Protein 50 mcg; Biological: Mixture of Ad26.RSV.preF 5*10^10 vp Plus RSV preF Protein 150 mcg; Biological: Mixture of Ad26.RSV.preF 1*10^11 vp Plus RSV preF Protein 50 mcg; Biological: Mixture of Ad26.RSV.preF 1*10^11 vp Plus RSV preF Protein 150 mcg; Biological: Seasonal Influenza Vaccine (Fluarix); Biological: Selected Regimen
Sponsor: Janssen Vaccines & Prevention B.V.
Recruiting - Conditions: Chronic Lymphocytic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Intervention: Biological: Inactivated Influenza Vaccine
Sponsor: Emory University
Recruiting - Conditions: Avian Influenza; Influenza Immunisation
Interventions: Other: Aqueous Cream B.P.; Drug: Imiquimod; Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza, Human
Interventions: Biological: Study group - quadrivalent recombinant hemagglutinin influenza vaccine; Biological: Control group - quadrivalent inactivated influenza vaccine
Sponsors: Laboratorios Liomont; Epic-CRO; ILS Clinical Research; Q Square Solutions
Recruiting - Conditions: Acute Respiratory Viral Infections; Influenza
Interventions: Drug: XC221 100 mg; Drug: XC221 200 mg; Drug: Placebo
Sponsor: PHARMENTERPRISES LLC
Recruiting - Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Influenza vaccination; Biological: Pneumococcal vaccination; Biological: Hepatitis B Virus (HBV) vaccination
Sponsors: Jesús Moreno Fernández; Castilla-La Mancha Health Service; University of Castilla-La Mancha
Recruiting - Conditions: Influenza; Healthy
Interventions: Biological: Fluzone®; Biological: FluMist®
Sponsors: Stanford University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza
Interventions: Biological: M-001; Biological: Saline
Sponsor: BiondVax Pharmaceuticals ltd.
Not yet recruiting - Condition: Influenza
Interventions: Biological: 4Fluart ID suspension for injection study drug 1 µg/0.1 ml, influenza vaccine (whole virion, inactivated, adjuvanted); Biological: 4Fluart ID suspension for injection study drug 2 µg/0.1 ml, influenza vaccine (whole virion, inactivated, adjuvanted); Biological: 3Fluart suspension for injection, influenza vaccine (whole virion, inactivated, adjuvanted)
Sponsors: Fluart Innovative Vaccine Ltd, Hungary; AMMY Ltd.; PRENET-ING Ltd.; AdWare Research Ltd.; Medyag Ltd.; MEGAPharma Ltd.; Drug Research Center Ltd.
Recruiting - Condition: Uptake of Influenza and Pneumococcal Vaccines
Intervention: Other: Educational intervention
Sponsors: Tan Tock Seng Hospital; Frontier Healthcare Group; OneCare Medical Group
Recruiting - Conditions: Sore Throat; Dysuria; Cough; Common Cold; Influenza
Interventions: Other: Physical Consultation; Other: Online Consultation
Sponsors: Region Skane; Doctrin; Capio Group; Capio Go; Lund University
Recruiting - Conditions: Influenza, Human; Pregnancy; Birth Defect
Intervention: Biological: Afluria Influenza Vaccine
Sponsor: Seqirus
Recruiting - Conditions: Influenza, Human; Pregnancy; Birth Defect
Interventions: Biological: Flucelvax Trivalent Influenza Vaccine; Biological: Flucelvax Quadrivalent Influenza Vaccine
Sponsor: Seqirus
Recruiting - Conditions: Influenza; Flu
Interventions: Biological: Shz QIV 0.25 mL, 2 doses; Biological: Shz QIV 0.5 mL, 2 doses; Biological: Shz QIV 0.5 mL, single dose
Sponsor: Sanofi Pasteur, a Sanofi Company
Not yet recruiting - Conditions: Hospital-Acquired Infection; Influenza
Intervention: Other: Questionnaire
Sponsor: Hospices Civils de Lyon
Not yet recruiting - Condition: Influenza, Human
Interventions: Drug: Elderberry Extract; Drug: Placebos
Sponsors: michael macknin; Pharmacare Laboratories pharmacare.com.au
Recruiting - Condition: Clinical Decision Support
Interventions: Other: Current Version of the Influenza Alert; Other: Alternate Modifications of the Influenza Alert
Sponsor: New York University School of Medicine
Recruiting - Condition: Multiple Sclerosis
Interventions: Drug: Plegridy; Drug: Prednisone; Drug: Tylenol Pill
Sponsors: Holy Name Medical Center, Inc.; Biogen
Recruiting - Conditions: Influenza Vaccine; Immune Response; Elderly; Vitamin D Deficiency; Metabolic Disease; Diabetes Mellitus
Intervention: Biological: Influenza Vaccine
Sponsors: Tan Tock Seng Hospital; Singapore Immunology Network; National Healthcare Group, Singapore
Recruiting - Conditions: Influenza, Human; Critical Illness; Influenza
Interventions: Drug: Favipiravir; Drug: Oseltamivir 75Mg Capsule
Sponsors: Capital Medical University; Beijing Institute of Pharmacology and Toxicology; University of Oxford; Centers for Disease Control and Prevention, China
Recruiting - Condition: Obesity
Interventions: Biological: Quadrivalent Influenza Vaccine; Biological: DTP Vaccine (Multiple Actives)
Sponsors: Women's and Children's Hospital, Australia; Sanofi Pasteur, a Sanofi Company
Recruiting - Conditions: Influenza With Pneumonia; Aspergillosis Invasive
Intervention:
Sponsor: Universitaire Ziekenhuizen Leuven
Recruiting - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Dietary Supplement: oral probiotics; Drug: aerosol inhaled amikacin; Biological: combined vaccination
Sponsors: Shanghai Zhongshan Hospital; The First Affiliated Hospital of Guangzhou Medical University; Ruijin Hospital
Not yet recruiting - Conditions: Bone Mineral Density; Grip Strength; Physical Performance
Intervention: Diagnostic Test: Bone densitometry measurement
Sponsor: Centre Hospitalier Régional d'Orléans
Not yet recruiting - Condition: Influenza A
Interventions: Drug: Pimodivir 600 mg; Drug: Placebo; Other: SOC Treatment
Sponsor: Janssen Research & Development, LLC
Recruiting - Condition: Influenza A
Interventions: Drug: Pimodivir 600 mg; Drug: Placebo; Other: SOC Treatment
Sponsor: Janssen Research & Development, LLC
Recruiting - Condition: Aspergillosis; Pulmonary, Invasive (Etiology)
Interventions: Drug: SOC +Posaconazole 18 MG/ML (milligram/milliliter); Other: standard of care (SOC)
Sponsors: Universitaire Ziekenhuizen Leuven; Merck Sharp & Dohme Corp.
Recruiting - Condition: H7N9 Influenza
Interventions: Biological: 7.5μg H7N9 Vaccine; Biological: Phosphate Buffer Solution; Biological: Aluminum Hydroxide Adjuvant; Biological: 15μg H7N9 Vaccine; Biological: 30μg H7N9 Vaccine
Sponsors: Shanghai Institute Of Biological Products; Henan Center for Disease Control and Prevention
Recruiting - Condition: Influenza A and B
Intervention: Diagnostic Test: RT-PCR H1N1
Sponsor: Dr. Nechama Sharon
Recruiting - Conditions: Influenza; Staphylococcus Aureus Pneumonia; PV Leukocidin
Intervention:
Sponsor: Central Hospital, Nancy, France
Recruiting - Condition: Influenza
Interventions: Drug: polyherbal formulation; Drug: Oseltamivir 75mg
Sponsor: Organic India
Recruiting - Condition: Influenza
Interventions: Biological: Vaccine administration by a pharmacist; Behavioral: Unmet vaccination needs identified and met; Behavioral: Vaccination forecast review and patient education
Sponsor: American Pharmacists Association Foundation
Recruiting - Condition: Influenza Vaccination
Intervention: Biological: Influenza vaccination
Sponsor: University of Pennsylvania
Recruiting - Conditions: Haemopoietic Stem Cell Transplantation; Allograft
Intervention: Drug: 4th dose of hexavalent vaccine 1 month after the 3rd dose
Sponsors: University Hospital, Grenoble; Centre Hospitalier Universitaire de Nice; University Hospital, Clermont-Ferrand; University Hospital of Saint-Etienne; Centre Hospitalier Universitaire de Besancon
Recruiting - Conditions: Influenza, Human; Myocardial Injury
Intervention:
Sponsor: Örebro University, Sweden
Recruiting - Condition: Influenza
Interventions: Drug: Nitazoxanide; Drug: Placebo
Sponsor: Romark Laboratories L.C.
Recruiting - Conditions: Influenza; H7N9 Influenza
Interventions: Biological: H7N9 antigen + adjuvant IB160; Biological: H7N9 antigen + adjuvant SE; Biological: H7N9 antigen without adjuvant; Biological: Placebo (PBS)
Sponsor: Butantan Institute
Recruiting - Conditions: Respiratory Tract Disease; Influenza
Intervention: Biological: influenza vaccine
Sponsors: Abt Associates; Centers for Disease Control and Prevention; Clalit Research Institute
Recruiting - Conditions: Influenza; Influenza Immunisation
Intervention: Biological: Influenza Virus Quadrivalent Inactivated Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Diffuse Intrinsic Pontine Glioma (DIPG)
Interventions: Biological: TTRNA-DC vaccines with GM-CSF; Biological: TTRNA-xALT; Drug: Cyclophosphamide + Fludarabine Lymphodepletive Conditioning; Drug: Dose-Intensified TMZ; Drug: Td vaccine; Biological: Autologous Hematopoietic Stem Cells (HSC)
Sponsor: University of Florida
Recruiting - Conditions: Influenza; Solid Organ Transplant
Intervention: Biological: standard of care influenza vaccine
Sponsor: University Health Network, Toronto
Not yet recruiting - Condition: Safety Issues
Interventions: Biological: Quadrivalent Influenza Vaccine; Biological: Trivalent Influenza Vaccine
Sponsor: PT Bio Farma
Recruiting - Condition: Influenza
Intervention: Biological: influenza vaccine
Sponsors: National Institute for Health and Welfare, Finland; Hospital District of Helsinki and Uusimaa
Recruiting - A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple SclerosisCondition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: SC Peginterferon beta-1a; Drug: SC interferon beta-1a; Drug: SC interferon beta-1b
Sponsors: Biogen; AMS Advanced Medical Services GmbH
Recruiting - Conditions: Influenza A H3N2; Influenza A H1N1
Interventions: Biological: FLU-IGIV; Other: Placebo for FLU-IGIV
Sponsor: Emergent BioSolutions
Recruiting - Conditions: Virus Diseases; RNA Virus Infections; Respiratory Tract Infections; Respiratory Tract Disease
Intervention: Biological: Quadrivalent VLP Influenza Vaccine
Sponsor: Medicago
Recruiting - Conditions: Avian Influenza; Influenza Immunisation
Interventions: Drug: AS03; Biological: Inactivated influenza H7N9 vaccine; Other: Phosphate Buffered Saline (PBS) diluent
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Viral Vaccines
Intervention: Biological: Inactivated influenza vaccine
Sponsor: University of Pennsylvania
Recruiting - Conditions: Basilar Thumb Arthritis; Wrist Fracture; Measure Pressure Distribution and Resultant Forces Needed
Intervention:
Sponsor: Shaare Zedek Medical Center
Not yet recruiting - Condition: Influenza
Interventions: Drug: Seasonal influenza vaccine; Drug: MVA-NP+M1; Drug: Sodium chloride
Sponsors: Vaccitech Limited; University of Oxford
Recruiting - Conditions: Tuberculosis; Polio; Diphtheria; Pertussis; Tetanus; Haemophilus Influenzae Type b Infection; Hepatitis B; Pneumococcal Infection
Intervention: Behavioral: SMS messages and automated calls
Sponsors: Aga Khan University; Grand Challenges Canada; University of British Columbia
Not yet recruiting - Conditions: Influenza; Vaccination
Intervention: Behavioral: Text message influenza vaccine reminders
Sponsors: Columbia University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); American Academy of Pediatrics; Children's Hospital of Philadelphia
Recruiting - Conditions: Influenza; Acute Respiratory Infection; Influenza-like Illness
Intervention: Behavioral: Educational text messages
Sponsors: Columbia University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Rheumatologic Disorder; Inflammatory Bowel Diseases; Immune Complex Diseases
Intervention: Biological: Influenza vaccine
Sponsors: Stony Brook University; University of North Carolina, Chapel Hill
Recruiting - Condition: Influenza A
Interventions: Drug: FFA, clarithromycin, oseltamivir; Drug: Oseltamivir alone
Sponsor: The University of Hong Kong
Recruiting - Condition: Osteoarthritis
Intervention: Device: Cartiva
Sponsor: Cartiva, Inc.
Recruiting - Conditions: Infectious Disease; Pneumonia, Bacterial; Influenza; Zoster; Herpes
Interventions: Behavioral: Pharmacist-led Intervention (PHARM); Behavioral: Peer-led Intervention (PEER)
Sponsors: Rutgers, The State University of New Jersey; Merck Sharp & Dohme Corp.; Thomas Jefferson University
Recruiting - Condition: Respiratory Disorders
Interventions: Biological: NTHi Mcat investigational vaccine (GSK3277511A); Biological: Placebo
Sponsor: GlaxoSmithKline
Recruiting - Condition: Flu
Interventions: Drug: Oseltamivir; Drug: Etilefrine; Drug: Diltiazem; Drug: Placebos
Sponsors: University Hospital, Lille; Ministry of Health, France
Recruiting - Condition: Influenza
Interventions: Biological: VRC-FLUNPF081-00-VP (HA-F A/Sing); Biological: VRC-FLUDNA082-00-VP (DNA A/Sing)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Pain; Quality of Life; Injection Site Reaction; Side Effect of Drug; Adverse Drug Event
Interventions: Biological: FLUAD; Biological: Fluzone High-Dose
Sponsors: Duke University; Centers for Disease Control and Prevention; Boston Medical Center; Children's Hospital Medical Center, Cincinnati
Recruiting - Condition: Hematopoietic Cell Transplantation
Interventions: Biological: Quadrivalent Inactivated Influenza Vaccine; Other: Laboratory Biomarker Analysis; Biological: Trivalent Influenza Vaccine
Sponsor: Vanderbilt-Ingram Cancer Center
Recruiting - Condition: Influenza, Human
Intervention: Biological: Fluarix
Sponsor: University of Rochester
Recruiting - Conditions: Influenza; Healthy
Interventions: Biological: FluMist® Quadrivalent; Biological: Fluzone® Quadrivalent vaccine
Sponsors: Stanford University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza
Interventions: Biological: FluBlok; Biological: Fluzone; Biological: FluCelVax
Sponsors: University of Rochester; National Institutes of Health (NIH)
Recruiting - Condition: Inflammatory Bowel Diseases
Interventions: Biological: Pneumococcal Pneumonia vaccine; Biological: Influenza vaccine; Biological: Hepatitis B vaccine
Sponsor: Boston Medical Center
Recruiting - Condition: Influenza A
Interventions: Drug: Low dose of VIS410 in addition to oseltamivir; Drug: High dose of VIS410 in addition to oseltamivir; Drug: Placebo in addition to oseltamivir
Sponsor: Visterra, Inc.
Recruiting - Condition: Influenza
Intervention: Biological: Flu Vaccine
Sponsors: Health Sciences North Research Institute; NOAMA NORTHERN ONTARIO ACADEMIC MEDICINE ASSOCIATION
Recruiting - Condition: Abdominal Cancer
Interventions: Drug: Cialis; Biological: Influenza vaccine
Sponsor: Ottawa Hospital Research Institute
Recruiting - Condition: Influenza
Interventions: Biological: Nasovac-S; Drug: Azithromycin
Sponsors: London School of Hygiene and Tropical Medicine; University of Edinburgh; Public Health England; University of Oxford; National Institute for Public Health and the Environment (RIVM)
Recruiting - Condition: Frailty
Intervention: Device: Obtain grip strength from a standardized gripometer
Sponsor: Yale University
Not yet recruiting - Conditions: Complement Deficiency; Antibody Deficiency; Chronic Sinus Infection; Meningitis, Bacterial; Pneumonia, Bacterial; Otitis Media; Streptococcal Infection; Neisseria Infections; Haemophilus Influenza; Pneumococcal Infections
Intervention: Biological: Immunological diagnosis tests
Sponsors: University Hospital, Lille; Imagine Institute; Octapharma; CSL Behring; Laboratoire français de Fractionnement et de Biotechnologies; Air Liquide SA; The Binding Site Ltd
Recruiting - Condition: Influenza, Human
Interventions: Diagnostic Test: Procalcitonin; Other: Pharmacist-Led Education
Sponsors: University of California, Davis; Roche Pharma AG
Recruiting - Condition: Cold
Interventions: Drug: Desloratadine+Phenylephrine+Ibuprofen; Drug: Placebo
Sponsor: Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting - Condition: Influenza, Human
Interventions: Drug: KT07 Capsule; Other: Placebo
Sponsor: Yiling Pharmaceutical Inc.
Recruiting - Conditions: Hematopoietic Cell Transplantation Recipient; Malignant Neoplasm; Influenza
Interventions: Biological: Trivalent Influenza Vaccine; Biological: Quadrivalent Influenza Vaccine; Other: Laboratory Biomarker Analysis
Sponsors: Vanderbilt-Ingram Cancer Center; National Cancer Institute (NCI)
Recruiting - Conditions: Myocardial Infarction; Influenza, Human; Influenza Vaccines; Heart Failure; Stroke
Interventions: Biological: Influenza vaccine; Biological: Placebo
Sponsors: Ole Frobert, MD, PhD; Swedish Heart Lung Foundation; Sanofi Pasteur, a Sanofi Company; Uppsala University; Lytics
Recruiting - Conditions: Heart Failure; Myocardial Infarction
Interventions: Biological: High Dose Trivalent Influenza Vaccine; Biological: Standard Dose Quadrivalent Influenza Vaccine
Sponsors: Brigham and Women's Hospital; National Heart, Lung, and Blood Institute (NHLBI); University of Wisconsin, Madison; University of Toronto; Boston VA Research Institute, Inc.; Patient-Centered Outcomes Research Institute
Recruiting - Conditions: Heart Failure; Influenza
Interventions: Other: Sterile saline; Drug: inactivated trivalent influenza vaccine
Sponsor: McMaster University
Recruiting - Conditions: Respiratory Syncytial Virus Infections; Influenza, Human
Interventions: Biological: RSV A Memphis 37; Biological: Influenza A/California/04/2009
Sponsors: Imperial College London; Medical Research Council; Wellcome Trust; National Institute for Health Research, United Kingdom
Recruiting - Condition: Brain Tumor
Interventions: Procedure: Electrocorticography (ECoG) with PMT Grids; Procedure: Electrocorticography (ECoG) with CorTec Grids; Procedure: Digital Glove Procedure; Procedure: Neurological Exam; Procedure: Electrocorticography (ECoG) with Ad-Tech Grids; Procedure: Direct Electrical Stimulation Mapping; Procedure: Grip Sensor Procedure
Sponsor: M.D. Anderson Cancer Center
Recruiting - Condition: Systemic Inflammatory Response
Interventions: Biological: Influenza Vaccine; Drug: Placebo
Sponsor: Health Sciences North Research Institute
Recruiting - Condition: Antibody Response to Hemagglutinin (HA) and Neuraminidase (NA) Post Influenza Challenge
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Head and Neck Squamous Cell Carcinoma; Head and Neck Cancer
Interventions: Drug: Tadalafil; Biological: Anti-MUC1 Vaccine; Biological: Anti-Influenza Vaccine; Other: Tadalafil Placebo; Other: Vaccine Placebo; Procedure: Peripheral Blood Collection; Procedure: DTH Skin Test; Procedure: Tumor specimen collection
Sponsor: Donald T. Weed
Recruiting - Condition: Influenza
Intervention: Biological: Influenza Virus Vaccine Inactivated
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Inflammatory Bowel Disease (IBD)
Intervention: Biological: Influenza vaccine
Sponsor: University of Wisconsin, Madison
Recruiting - Condition: Influenza
Intervention: Biological: Influenza Virus Vaccine Inactivated
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: H1N1 Influenza Healthy Volunteers
Interventions: Biological: CR6261; Biological: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza
Interventions: Drug: Peramivir; Drug: Oseltamivir
Sponsor: BioCryst Pharmaceuticals
Recruiting - Condition: Influenza, Human
Interventions: Other: Blood sample; Other: Nasal swab; Other: Oropharyngeal swab; Other: Stool sample; Other: Symptom checklist
Sponsor: St. Jude Children's Research Hospital
Recruiting - Conditions: Metabolic Myopathies; Exercise Test; Myalgia
Interventions: Device: functional test; Genetic: matching genotype with phenotype
Sponsor: University Hospital, Brest
Recruiting - Conditions: Influenza A; Influenza B
Interventions: Biological: Intravenous hyperimmune immunoglobulin (IVIG); Biological: Placebo for IVIG
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); University of Minnesota, MN; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
Recruiting - Conditions: Influenza; Immunization; Older Adults; Over Age 75
Intervention: Biological: Influenza
Sponsor: Johns Hopkins University
Recruiting - Condition: Influenza
Intervention: Other: Data collection
Sponsor: GlaxoSmithKline
Recruiting - Condition: Influenza
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Ohio State University
Recruiting - Condition: Influenza
Interventions: Drug: Ergoferon; Drug: Oseltamivir
Sponsor: Materia Medica Holding
Recruiting - Conditions: Adenovirus; Anesthesia; Anxiety; Anxiolysis; Autism; Autistic Disorder; Bacterial Meningitis; Bacterial Septicemia; Benzodiazepine; Bipolar Disorder; Bone and Joint Infections; Central Nervous System Infections; Convulsions; Cytomegalovirus Retinitis; Early-onset Schizophrenia Spectrum Disorders; Epilepsy; General Anesthesia; Gynecologic Infections; Herpes Simplex Virus; Infantile Hemangioma; Infection; Inflammation; Inflammatory Conditions; Intra-abdominal Infections; Lower Respiratory Tract Infections; Migraines; Pain; Pneumonia; Schizophrenia; Sedation; Seizures; Skeletal Muscle Spasms; Skin and Skin-structure Infections; Thromboprophylaxis; Thrombosis; Treatment-resistant Schizophrenia; Urinary Tract Infections; Withdrawal; Sepsis; Gram-negative Infection; Bradycardia; Cardiac Arrest; Cardiac Arrhythmia; Staphylococcal Infections; Nosocomial Pneumonia; Neuromuscular Blockade; Methicillin Resistant Staphylococcus Aureus; Endocarditis; Neutropenia; Headache
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
Sponsors: Daniel Benjamin; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); The EMMES Corporation
Recruiting - Condition: Influenza, Human
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Influenza; Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV); Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Intervention:
Sponsors: University of Minnesota - Clinical and Translational Science Institute; National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH)
Recruiting - Condition: Influenza
Intervention:
Sponsor: University of Pittsburgh
Recruiting - Condition: Influenza
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Mycobacterium Infections, Atypical; Granulomatous Disease, Chronic; Job's Syndrome; Influenza, Human
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
Clinical Trial Locations